ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,850 | +2.8% | 89,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,800 | +25.3% | 89,700 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,436 | -16.7% | 89,700 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $1,723 | -99.9% | 89,700 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $1,236,000 | -35.5% | 89,700 | -40.3% | 0.00% | -33.3% |
| Q2 2022 | $1,915,000 | -20.1% | 150,200 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $2,396,000 | -18.5% | 150,200 | +14.2% | 0.01% | -14.3% |
| Q4 2021 | $2,939,000 | -23.4% | 131,500 | +1.7% | 0.01% | -36.4% |
| Q3 2021 | $3,836,000 | -30.5% | 129,300 | 0.0% | 0.01% | -31.2% |
| Q2 2021 | $5,521,000 | +137.7% | 129,300 | +138.1% | 0.02% | +100.0% |
| Q1 2021 | $2,323,000 | -10.9% | 54,300 | +14.8% | 0.01% | -20.0% |
| Q4 2020 | $2,607,000 | +55.5% | 47,300 | -35.8% | 0.01% | +42.9% |
| Q3 2020 | $1,677,000 | – | 73,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |